Vellanki Sruthi, Trikannad Ashwini Kumar Anup Kumar, Stoffel Ryan, Vellanki Sravya, Nuffer Zachary
Internal Medicine, Union Hospital, Terre Haute, USA.
Medicine, Indiana University School of Medicine, Terre Haute, USA.
Cureus. 2022 Feb 26;14(2):e22637. doi: 10.7759/cureus.22637. eCollection 2022 Feb.
Coronavirus disease 2019 (COVID-19) is known to manifest with bilateral pneumonia and acute respiratory distress syndrome. This infection with severe acute respiratory syndrome coronavirus 2 (SAR-CoV-2) is alarming because it not only affects the respiratory system but may also cause thromboembolic events. Multiple studies have reported procoagulation/hypercoagulable complications in COVID-19. This case series is a valuable addition to the literature because it reflects unique presentations of thrombotic events in COVID-19 patients. We report two cases in which patients presented with thromboembolic complications secondary to COVID-19 infection: one with severe bowel ischemia and the other with blue toe syndrome. To formulate management strategies to prevent fatal outcomes for patients with COVID-19, physicians must be vigilant in identifying life-threatening thromboembolic complications from this disease.
2019冠状病毒病(COVID-19)已知表现为双侧肺炎和急性呼吸窘迫综合征。这种由严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引起的感染令人担忧,因为它不仅影响呼吸系统,还可能导致血栓栓塞事件。多项研究报告了COVID-19患者出现促凝/高凝并发症。这个病例系列是对文献的一个有价值的补充,因为它反映了COVID-19患者血栓形成事件的独特表现。我们报告了两例患者,他们因COVID-19感染继发血栓栓塞并发症:一例为严重肠缺血,另一例为蓝趾综合征。为了制定管理策略以防止COVID-19患者出现致命后果,医生必须警惕识别这种疾病危及生命的血栓栓塞并发症。